Antidote Industry Research Report 2024

Antidote Industry Research Report 2024


Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.

Highlights

The global Antidote market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global Antidote key players include Roche, Pfizer, Bayer, etc. Global top three manufacturers hold a share about 15%.
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share about 50 percent.
In terms of product, Chemical Antidotes is the largest segment, with a share about 45%. And in terms of application, the largest application is Pesticide Poisoning, followed by Heavy Metal Poisoning.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antidote, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidote.
The Antidote market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antidote market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antidote companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Roche
Pfizer
Bayer
Johnson & Johnson
Novartis
Eli Lilly
Teva
Boehringer Ingelheim
Mylan
Fresenius Kabi
Baxter
Furen Pharmaceutical

Product Type Insights

Global markets are presented by Antidote type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Antidote are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Antidote segment by Type

Chemical Antidotes
Physical Antidotes
Pharmacological Antidotes

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Antidote market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Antidote market.
Antidote Segment by Application
Pesticide Poisoning
Heavy Metal Poisoning
Animal Bites Poisoning
Cyanide Poisoning
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antidote market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidote market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Antidote and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Antidote industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidote.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Antidote companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Antidote by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
1.2.2 Chemical Antidotes
1.2.3 Physical Antidotes
1.2.4 Pharmacological Antidotes
2.3 Antidote by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Pesticide Poisoning
2.3.3 Heavy Metal Poisoning
2.3.4 Animal Bites Poisoning
2.3.5 Cyanide Poisoning
2.3.6 Others
2.4 Assumptions and Limitations
3 Antidote Breakdown Data by Type
3.1 Global Antidote Historic Market Size by Type (2019-2024)
3.2 Global Antidote Forecasted Market Size by Type (2025-2030)
4 Antidote Breakdown Data by Application
4.1 Global Antidote Historic Market Size by Application (2019-2024)
4.2 Global Antidote Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Antidote Market Perspective (2019-2030)
5.2 Global Antidote Growth Trends by Region
5.2.1 Global Antidote Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Antidote Historic Market Size by Region (2019-2024)
5.2.3 Antidote Forecasted Market Size by Region (2025-2030)
5.3 Antidote Market Dynamics
5.3.1 Antidote Industry Trends
5.3.2 Antidote Market Drivers
5.3.3 Antidote Market Challenges
5.3.4 Antidote Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Antidote Players by Revenue
6.1.1 Global Top Antidote Players by Revenue (2019-2024)
6.1.2 Global Antidote Revenue Market Share by Players (2019-2024)
6.2 Global Antidote Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Antidote Head office and Area Served
6.4 Global Antidote Players, Product Type & Application
6.5 Global Antidote Players, Date of Enter into This Industry
6.6 Global Antidote Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Antidote Market Size (2019-2030)
7.2 North America Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Antidote Market Size by Country (2019-2024)
7.4 North America Antidote Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Antidote Market Size (2019-2030)
8.2 Europe Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Antidote Market Size by Country (2019-2024)
8.4 Europe Antidote Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Antidote Market Size (2019-2030)
9.2 Asia-Pacific Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Antidote Market Size by Country (2019-2024)
9.4 Asia-Pacific Antidote Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Antidote Market Size (2019-2030)
10.2 Latin America Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Antidote Market Size by Country (2019-2024)
10.4 Latin America Antidote Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Antidote Market Size (2019-2030)
11.2 Middle East & Africa Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Antidote Market Size by Country (2019-2024)
11.4 Middle East & Africa Antidote Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Antidote Introduction
11.1.4 Roche Revenue in Antidote Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Antidote Introduction
11.2.4 Pfizer Revenue in Antidote Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Antidote Introduction
11.3.4 Bayer Revenue in Antidote Business (2017-2022)
11.3.5 Bayer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Antidote Introduction
11.4.4 Johnson & Johnson Revenue in Antidote Business (2017-2022)
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Antidote Introduction
11.5.4 Novartis Revenue in Antidote Business (2017-2022)
11.5.5 Novartis Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Antidote Introduction
11.6.4 Eli Lilly Revenue in Antidote Business (2017-2022)
11.6.5 Eli Lilly Recent Development
11.7 Teva
11.7.1 Teva Company Detail
11.7.2 Teva Business Overview
11.7.3 Teva Antidote Introduction
11.7.4 Teva Revenue in Antidote Business (2017-2022)
11.7.5 Teva Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Antidote Introduction
11.8.4 Boehringer Ingelheim Revenue in Antidote Business (2017-2022)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Mylan
11.9.1 Mylan Company Detail
11.9.2 Mylan Business Overview
11.9.3 Mylan Antidote Introduction
11.9.4 Mylan Revenue in Antidote Business (2017-2022)
11.9.5 Mylan Recent Development
11.10 Fresenius Kabi
11.10.1 Fresenius Kabi Company Detail
11.10.2 Fresenius Kabi Business Overview
11.10.3 Fresenius Kabi Antidote Introduction
11.10.4 Fresenius Kabi Revenue in Antidote Business (2017-2022)
11.10.5 Fresenius Kabi Recent Development
11.11 Baxter
11.11.1 Baxter Company Detail
11.11.2 Baxter Business Overview
11.11.3 Baxter Antidote Introduction
11.11.4 Baxter Revenue in Antidote Business (2017-2022)
11.11.5 Baxter Recent Development
11.12 Furen Pharmaceutical
11.12.1 Furen Pharmaceutical Company Detail
11.12.2 Furen Pharmaceutical Business Overview
11.12.3 Furen Pharmaceutical Antidote Introduction
11.12.4 Furen Pharmaceutical Revenue in Antidote Business (2017-2022)
11.12.5 Furen Pharmaceutical Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Antidote Market Size by Type (2019-2024) & (US$ Million)
Table 6. Global Antidote Revenue Market Share by Type (2019-2024)
Table 7. Global Antidote Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 8. Global Antidote Revenue Market Share by Type (2025-2030)
Table 9. Global Antidote Market Size by Application (2019-2024) & (US$ Million)
Table 10. Global Antidote Revenue Market Share by Application (2019-2024)
Table 11. Global Antidote Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 12. Global Antidote Revenue Market Share by Application (2025-2030)
Table 13. Global Antidote Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Antidote Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Antidote Market Share by Region (2019-2024)
Table 16. Global Antidote Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Antidote Market Share by Region (2025-2030)
Table 18. Antidote Market Trends
Table 19. Antidote Market Drivers
Table 20. Antidote Market Challenges
Table 21. Antidote Market Restraints
Table 22. Global Top Antidote Manufacturers by Revenue (US$ Million) & (2019-2024)
Table 23. Global Antidote Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Antidote Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 25. Global Key Players of Antidote, Headquarters and Area Served
Table 26. Global Antidote Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Antidote by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. North America Antidote Market Size by Country (2019-2024) & (US$ Million)
Table 32. North America Antidote Market Size by Country (2025-2030) & (US$ Million)
Table 33. Europe Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Europe Antidote Market Size by Country (2019-2024) & (US$ Million)
Table 35. Europe Antidote Market Size by Country (2025-2030) & (US$ Million)
Table 36. Asia-Pacific Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Asia-Pacific Antidote Market Size by Country (2019-2024) & (US$ Million)
Table 38. Asia-Pacific Antidote Market Size by Country (2025-2030) & (US$ Million)
Table 39. Latin America Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 40. Latin America Antidote Market Size by Country (2019-2024) & (US$ Million)
Table 41. Latin America Antidote Market Size by Country (2025-2030) & (US$ Million)
Table 42. Middle East & Africa Antidote Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 43. Middle East & Africa Antidote Market Size by Country (2019-2024) & (US$ Million)
Table 44. Middle East & Africa Antidote Market Size by Country (2025-2030) & (US$ Million)
Table 45. Roche Company Detail
Table 46. Roche Business Overview
Table 47. Roche Antidote Product
Table 48. Roche Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 49. Roche Recent Development
Table 50. Pfizer Company Detail
Table 51. Pfizer Business Overview
Table 52. Pfizer Antidote Product
Table 53. Pfizer Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Bayer Company Detail
Table 56. Bayer Business Overview
Table 57. Bayer Antidote Product
Table 58. Bayer Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 59. Bayer Recent Development
Table 60. Johnson & Johnson Company Detail
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Antidote Product
Table 63. Johnson & Johnson Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Novartis Company Detail
Table 66. Novartis Business Overview
Table 67. Novartis Antidote Product
Table 68. Novartis Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Eli Lilly Company Detail
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly Antidote Product
Table 73. Eli Lilly Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 74. Eli Lilly Recent Development
Table 75. Teva Company Detail
Table 76. Teva Business Overview
Table 77. Teva Antidote Product
Table 78. Teva Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 79. Teva Recent Development
Table 80. Boehringer Ingelheim Company Detail
Table 81. Boehringer Ingelheim Business Overview
Table 82. Boehringer Ingelheim Antidote Product
Table 83. Boehringer Ingelheim Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 84. Boehringer Ingelheim Recent Development
Table 85. Mylan Company Detail
Table 86. Mylan Business Overview
Table 87. Mylan Antidote Product
Table 88. Mylan Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 89. Mylan Recent Development
Table 90. Fresenius Kabi Company Detail
Table 91. Fresenius Kabi Business Overview
Table 92. Fresenius Kabi Antidote Product
Table 93. Fresenius Kabi Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 94. Fresenius Kabi Recent Development
Table 95. Baxter Company Detail
Table 96. Baxter Business Overview
Table 97. Baxter AntidoteProduct
Table 98. Baxter Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 99. Baxter Recent Development
Table 100. Furen Pharmaceutical Company Detail
Table 101. Furen Pharmaceutical Business Overview
Table 102. Furen Pharmaceutical AntidoteProduct
Table 103. Furen Pharmaceutical Revenue in Antidote Business (2017-2022) & (US$ Million)
Table 104. Furen Pharmaceutical Recent Development
Table 105. Roche Company Information
Table 106. Roche Business Overview
Table 107. Roche Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 108. Roche Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 109. Roche Recent Development
Table 110. Pfizer Company Information
Table 111. Pfizer Business Overview
Table 112. Pfizer Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 113. Pfizer Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 114. Pfizer Recent Development
Table 115. Bayer Company Information
Table 116. Bayer Business Overview
Table 117. Bayer Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 118. Bayer Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 119. Bayer Recent Development
Table 120. Johnson & Johnson Company Information
Table 121. Johnson & Johnson Business Overview
Table 122. Johnson & Johnson Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 123. Johnson & Johnson Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 124. Johnson & Johnson Recent Development
Table 125. Novartis Company Information
Table 126. Novartis Business Overview
Table 127. Novartis Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 128. Novartis Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 129. Novartis Recent Development
Table 130. Eli Lilly Company Information
Table 131. Eli Lilly Business Overview
Table 132. Eli Lilly Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 133. Eli Lilly Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 134. Eli Lilly Recent Development
Table 135. Teva Company Information
Table 136. Teva Business Overview
Table 137. Teva Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 138. Teva Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 139. Teva Recent Development
Table 140. Boehringer Ingelheim Company Information
Table 141. Boehringer Ingelheim Business Overview
Table 142. Boehringer Ingelheim Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 143. Boehringer Ingelheim Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 144. Boehringer Ingelheim Recent Development
Table 145. Mylan Company Information
Table 146. Mylan Business Overview
Table 147. Mylan Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 148. Mylan Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 149. Mylan Recent Development
Table 150. Fresenius Kabi Company Information
Table 151. Fresenius Kabi Business Overview
Table 152. Fresenius Kabi Antidote Revenue in Antidote Business (2019-2024) & (US$ Million)
Table 153. Fresenius Kabi Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 154. Fresenius Kabi Recent Development
Table 155. Baxter Company Information
Table 156. Baxter Business Overview
Table 157. Baxter AntidoteRevenue in Antidote Business (2019-2024) & (US$ Million)
Table 158. Baxter Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio
Table 159. Baxter Recent Development
Table 160. Furen Pharmaceutical Company Information
Table 161. Furen Pharmaceutical Business Overview
Table 162. Furen Pharmaceutical AntidoteRevenue in Antidote Business (2019-2024) & (US$ Million)
Table 163. Furen Pharmaceutical Revenue in Antidote Business (2019-2024) & (US$ Million) Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings